The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Kiniksa Pharmaceuticals, Ltd(NASDAQ:KNSA) 
Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need worldwide. Its product candidates include Rilonace...
Website: http://www.kiniksa.com
Founded: 2015
Full Time Employees: 135
Sector: Healthcare
Industry: Biotechnology
Kiniksa Pharmaceuticals Days Payable Outstanding ttm (DPO)
Kiniksa Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Kiniksa Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Kiniksa Pharmaceuticals Op Cashflow Per Share ttm
Kiniksa Pharmaceuticals Free Cashflow Per Share ttm
Kiniksa Pharmaceuticals Cash Per Share ttm
Kiniksa Pharmaceuticals P/S ratio ttm
Kiniksa Pharmaceuticals (GAAP) P/E ratio ttm
Kiniksa Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.